Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/84810
Title: Anti-Parkinson’s evaluation of Brassica juncea leaf extract and underlying mechanism of its phytochemicals
Authors: Saleem, Uzma
Bibi, Shabana
Shah, Muhammad Ajmal
Ahmad, Bashir
Saleem, Ammara
Chauhdary, Zunera
Anwar, Fareeha
Javaid, Nimra
Hira, Sundas
Akhtar, Muhammad Furqan
Shah, Ghulam Mujtaba
Khan, Muhammad Saad
Muhammad, Haji
Qasim, Muhammad
Alqarni, Mohammad
Algarni, Majed A.
Blundell, Renald
Vargas-de la Cruz, Celia
Herrera-Calderon, Oscar
Alhasani, Reem Hasaballah
Keywords: Parkinson’s disease
Cellular therapy
Oxidative stress
Antioxidants
Nervous system -- Degeneration
Neuroprotective agents
Issue Date: 2021
Publisher: Frontiers
Citation: Saleem, U., Bibi, S., Shah, M. A., Ahmad, B., Saleem, A., Chauhdary, Z.,... Alhasani, R. H. (2021). Anti-Parkinson’s evaluation of Brassica juncea leaf extract and underlying mechanism of its phytochemicals. Frontiers in Bioscience-Landmark, 2. 1-21.
Abstract: Parkinson’s disease (PD) is asso- ciated with progressive neuronal damage and dysfunction. Oxidative stress helps to regulate neurodegenerative and neuronal dysfunction. Natural compounds could attenuate oxidative stress in a variety of neurological disorders. B. juncea is a rich source of antioxidants. The present study aimed to evaluate the therapeutic potential of B. juncea leaves for the treatment of PD by applying behavioral, in vivo and in silico studies. For in vivo studies rats were divided into six groups (n = 6). Group-I served as nor- mal control (vehicle control). Group-II was disease con- trol (haloperidol 1 mg/kg). Group-III was kept as a stan- dard group (L-Dopa 100 mg/kg + carbidopa 25 mg/kg). Groups (IV–VI) were the treatment groups, receiving ex- tract at 200-, 400- and 600 mg/kg doses respectively, for 21 days orally.
Results: In vivo study results showed that the extract was found to improve muscles strength, motor co- ordination, and balance in PD. These behavioral outcomes were consistent with the recovery of endogenous antioxi- dant defence in biochemical analysis which was further cor- roborated with histopathological ameliorations. Dopamine levels increased and monoamine oxidase B (MAO-B) levels decreased dose-dependently in the brain during the study. Herein, we performed molecular docking analysis of the proposed extracted phytochemicals has explained that four putative phytochemicals (sinapic acid, rutin, ferulic acid, and caffeic acid) have presented very good results in terms of protein-ligand binding interactions as well as absorption, distribution, metabolism, excretion & toxicity (ADMET) profile estimations.
Conclusion: The undertaken study concluded the anti-Parkinson activity of B. juncea and fur- ther suggests developments on its isolated compounds in PD therapeutics.
URI: https://www.um.edu.mt/library/oar/handle/123456789/84810
Appears in Collections:Scholarly Works - FacM&SPB

Files in This Item:
File Description SizeFormat 
Landmark21060205-V2 (1).pdf15.93 MBAdobe PDFView/Open


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.